Research Article

Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study

Figure 2

Columns of supernatant level (pg/mL) of IL-1ra, IL-2, IL-4, IL-6, IL-9, IL-12(p70), IL-15, IL-17, Eotaxin, FGF-basic, IFN-γ, IP-10, MIP-1α, PDGF-BB, and VEGF both at 37°C and at 40°C, in untreated condition and after administration of LPS alone or in combination with GOH or Typ. * ; ** ; *** ; one-way ANOVA test followed by Bonferroni’s multiple comparison test. LPS: lipopolysaccharide; GOH: geraniol; Typ: Tipifarnib.
715465.fig.002a
(a)
715465.fig.002b
(b)
715465.fig.002c
(c)
715465.fig.002d
(d)
715465.fig.002e
(e)
715465.fig.002f
(f)
715465.fig.002g
(g)
715465.fig.002h
(h)
715465.fig.002i
(i)
715465.fig.002j
(j)
715465.fig.002k
(k)
715465.fig.002l
(l)
715465.fig.002m
(m)
715465.fig.002n
(n)
715465.fig.002o
(o)